Chemocentryx Market Risk Adjusted Performance

CCXI -  USA Stock  

USD 16.57  0.58  3.63%

Chemocentryx market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Chemocentryx or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools

Search Technical Indicator 

 
Refresh
Chemocentryx has current Market Risk Adjusted Performance of 1.12.
MRAP 
 = 
ER[a] + (1/BETA - 1) 
ER[a] - RFR) 
 = 
1.12
ER[a] = Expected return on investing in Chemocentryx
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Chemocentryx Market Risk Adjusted Performance Relative To Other Indicators

Chemocentryx is rated second in market risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about  15.27  of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Chemocentryx is roughly  15.27 
Compare Chemocentryx to competition

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas